Early BMD response at the lumbar spine to teriparatide: Six-month results from the EUROFORS trial

被引：0
|
作者：
Minne, H
Eastell, R
Nicholson, T
Brixen, K
Obermayer-Pietsch, B
Farrerons, J
Garces, C
Marin, F
Ochs, P
Nickelsen, T
机构：
[1] Univ Sheffield, Ctr Clin Sci, Sheffield S10 2TN, S Yorkshire, England
[2] Klin Furstenhof, Bad Pyrmont, Germany
[3] Eli Lilly & Co, Dept Biostat, Windlesham, Surrey, England
[4] Universitetshosp Odense, Dept Endocrinol, Odense, Denmark
[5] Med Universitaetsklin, Dept Endocrinol, Graz, Austria
[6] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[7] Eli Lilly & Co, Dept Med, Madrid, Spain
[8] Eli Lilly & Co, Dept Med, Bad Homburg, Spain
来源：
BONE | 2005年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S446 / S446
页数：1
相关论文
共 50 条
  • [1] Early and late response of BMD at lumbar spine and total hip to teriparatide in postmenopausal osteoporosis
    Hoene, B.
    Heberling, H. -J.
    Mehnert-Solzer, C.
    Nickelsen, T.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S22 - S23
  • [2] Early Change in PINP Correlates with Lumbar Spine BMD More Strongly with Abaloparatide than with Teriparatide: Results of the ACTIVE trial.
    Eastell, Richard
    Mitlak, Bruce H.
    Wang, Yamei
    Hu, Ming-yi
    Fitzpatrick, Lorraine A.
    Black, Dennis M.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S378 - S378
  • [3] Early BMD response to teriparatide (RHPTH 1-34) in patients with and without prior antiresorptive treatment: Interim results from the EUROFORS study
    Nickelsen, T
    Fogelman, I
    Fraser, WD
    Blumsohn, A
    Phelan, T
    Eastell, R
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S12 - S12
  • [4] Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE
    R. Eastell
    B. H. Mitlak
    Y. Wang
    M. Hu
    L. A. Fitzpatrick
    D. M. Black
    [J]. Osteoporosis International, 2019, 30 : 667 - 673
  • [5] Early BMD response to teriparatide (rhPTH 1-34) in patients with and without prior antiresorptive treatment: Interim results from the EUROFORS study.
    Farrerons, J
    Eastell, R
    Minne, H
    Audran, M
    Lyritis, G
    Simoes, E
    Marin, F
    Nicholson, T
    Ochs, P
    Alonso, R
    Nickelsen, TN
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S98 - S98
  • [6] Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE
    Eastell, R.
    Mitlak, B. H.
    Wang, Y.
    Hu, M.
    Fitzpatrick, L. A.
    Black, D. M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 (03) : 667 - 673
  • [7] Six-month clinical and angiographic results of the SMART Trial
    Heuser, R
    Kuntz, R
    Lansky, A
    Ho, KKL
    Pino-Mauch, B
    Reduto, L
    Badger, R
    Coleman, P
    Whitlow, P
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 64A - 65A
  • [8] Early treatment response of ocrelizumab in persons with multiple sclerosis: six-month results
    Ozakbas, S.
    Ozcelik, S.
    Kaya, E.
    Ozdogar, A. T.
    Sagici, O.
    Baba, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 278 - 278
  • [9] Early response of BMD and back pain to 6 months of teriparatide (RHPTH 1-34) in patients with and without prior antiresorptive treatment:: Interim results from the EUROFORS study
    Audran, M
    Eastell, R
    Minne, H
    Nicholson, T
    Boonen, S
    Avramidis, A
    Beardsworth, A
    Liu-Léage, S
    Ginis, A
    Nickelsen, T
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 93 - 93
  • [10] Obesity Reduction Black Intervention Trial (ORBIT): Six-month Results
    Stolley, Melinda R.
    Fitzgibbon, Marian L.
    Schiffer, Linda
    Sharp, Lisa K.
    Singh, Vicky
    Van Horn, Linda
    Dyer, Alan
    [J]. OBESITY, 2009, 17 (01) : 100 - 106
12345